IFNB1 and myeloid sarcoma: Diverse modes of action of IFN-β help contributing to its anti-inflammatory and immunoregulatory effects in MS, such as induction of autoreactive T cell apoptosis and inhibition of inflammatory cell migration across the blood–brain barrier (BBB), etc. [55, 56].